C4 Therapeutics, Inc. (CCCC) Institutional Ownership & Insider Trading
147 institutions reported holding C4 Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 1 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CCCCC4 Therapeutics, Inc.Follow CCCC — free
—
Price chart with a free account
- Market cap
- 376.5M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters147 institutions held 95.6% of the shares. Across filers that reported both quarters, shares held changed +38.4%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 147 | 118 | +38.4% | 52 | 48 | 28 | 25 |
| Mar 26 | 123 | 85 | +8.3% | 38 | 28 | 29 | 9 |
| Dec 25 | 100 | 80 | +55.1% | 41 | 21 | 20 | 12 |
| Sep 25 | 96 | 53 | -4.4% | 26 | 19 | 33 | 25 |
| Jun 25 | 101 | 55 | -14.9% | 30 | 23 | 31 | 37 |
| Mar 25 | 114 | 64 | -0.4% | 32 | 25 | 28 | 22 |
| Dec 24 | 113 | 64 | +0.0% | 35 | 17 | 29 | 28 |
| Sep 24 | 115 | 64 | +3.3% | 36 | 27 | 29 | 23 |
C4 Therapeutics, Inc. — questions
- Who owns C4 Therapeutics, Inc. stock?
- 147 institutions reported C4 Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: MORGAN STANLEY (7.2%), RA CAPITAL MANAGEMENT, L.P. (6.5%), BlackRock, Inc. (6.4%).
- Are C4 Therapeutics, Inc. insiders buying or selling?
- 1 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from C4 Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.